BFLY
Bearish signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Unavailable or mixed. Current ratio 3.83 · operating margin -89% — readings disagree
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
VENTE TOTALE: 5 980 titres (~59 866,55 $ US)
- Insiders
- DEVIVO JOSEPH
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$59,867
Avg sell (VWAP, 90d window) $7.07 vs last close —
- Last activity
- 2026-09-23
- Last synced
-
2026-09-25 21:09:17
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-04 | Carlson Megan | Sell | 13,804 | $7.30 | $100,797 | Form 4 |
| 2026-09-04 | Cashman Steve | Sell | 140,112 | $7.30 | $1,023,098 | Form 4 |
| 2026-09-02 | Caezza Nicholas | Sell | 1,709 | $8.15 | $13,927 | Form 4 |
| 2026-08-11 | Caezza Nicholas | Sell | 10,000 | $9.75 | $97,500 | Form 4 |
| 2026-08-10 | DEVIVO JOSEPH | Sell | 68,346 | $10.01 | $684,075 | Form 4 |
| 2026-07-31 | Carlson Megan | Sell | 68,852 | $7.86 | $541,383 | Form 4 |
| 2026-07-22 | ROTHBERG JONATHAN M | Sell | 36,366 | $6.47 | $235,281 | Form 4 |
| 2026-07-21 | ROTHBERG JONATHAN M | Sell | 753,320 | $6.74 | $5,074,288 | Form 4 |
| 2026-07-20 | DEVIVO JOSEPH | Sell | 211,798 | $6.56 | $1,389,395 | Form 4 |
| 2026-07-20 | Doherty John N. | Sell | 57,136 | $6.56 | $374,812 | Form 4 |
| 2026-07-20 | Ku Victor | Sell | 48,540 | $6.56 | $318,422 | Form 4 |
| 2026-07-20 | ROTHBERG JONATHAN M | Sell | 1,177,276 | $6.61 | $7,786,268 | Form 4 |
| 2026-07-17 | ROTHBERG JONATHAN M | Sell | 1,195,857 | $6.60 | $7,887,753 | Form 4 |
| 2026-07-16 | ROTHBERG JONATHAN M | Sell | 253,867 | $7.09 | $1,799,638 | Form 4 |
| 2026-07-15 | ROTHBERG JONATHAN M | Sell | 1,730,319 | $7.32 | $12,670,780 | Form 4 |
| 2026-07-14 | ROTHBERG JONATHAN M | Sell | 815,632 | $7.72 | $6,294,885 | Form 4 |
| 2026-07-07 | DEVIVO JOSEPH | Sell | 204,725 | $7.87 | $1,611,800 | Form 4 |
| 2026-07-07 | Doherty John N. | Sell | 55,229 | $7.87 | $434,818 | Form 4 |
| 2026-07-07 | Ku Victor | Sell | 35,649 | $7.87 | $280,665 | Form 4 |
| 2026-07-02 | Carlson Megan | Sell | 41,303 | $7.96 | $328,937 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bearish signalScored 2026-08-14
BFLY presents a structurally weak profile: persistent operating losses, negative free cash flow, and no credible near-term path to profitability undermine the moderate liquidity cushion.
The first sentence of the analysis written for BFLY on 2026-08-14 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 46.9% | 59.5% | 25.6% | 53.8% | 27.3% | |
| Ebit Margin | -77.3% | -86.8% | -202.8% | -229.8% | -50.6% | |
| Ebitda Margin | -69.0% | -74.2% | -186.7% | -221.8% | -47.2% | |
| Operating Profit Margin | -88.5% | -90.7% | -221.0% | -263.0% | -308.0% | |
| Pretax Profit Margin | -78.8% | -88.4% | -202.8% | -229.8% | -51.6% | |
| Continuous Operations Profit Margin | -79.0% | -88.3% | -202.9% | -229.9% | -51.8% | |
| Net Profit Margin | -79.0% | -88.3% | -202.9% | -229.9% | -51.8% | |
| Bottom Line Profit Margin | -79.0% | -88.3% | -202.9% | -229.9% | -51.8% | |
| Current Ratio | 3.825 | 3.995 | 5.224 | 6.958 | 10.273 | |
| Quick Ratio | 2.883 | 2.527 | 3.574 | 5.789 | 9.546 | |
| Solvency Ratio | -0.686 | -0.712 | -1.462 | -1.765 | -0.244 | |
| Cash Ratio | 2.311 | 1.841 | 3.041 | 3.167 | 8.486 | |
| Price To Earnings Ratio | -12.258 | -9.176 | -1.662 | -2.929 | -35.211 | |
| Price To Earnings Growth Ratio | 1.389 | 0.192 | 0.073 | -0.009 | 0.355 | |
| Forward Price To Earnings Growth Ratio | 1.389 | 0.192 | 0.073 | -0.009 | 0.355 | |
| Price To Earnings Diluted Ratio | -12.258 | -9.176 | -1.662 | -2.929 | -35.211 | |
| Price To Earnings Diluted Growth Ratio | 1.389 | 0.192 | 0.073 | -0.009 | 0.355 | |
| Price To Book Ratio | 4.792 | 3.912 | 1.008 | 1.511 | 2.597 | |
| Price To Sales Ratio | 9.621 | 8.049 | 3.366 | 6.699 | 18.585 | |
| Price To Free Cash Flow Ratio | -58.516 | -14.875 | -2.121 | -2.623 | -5.901 | |
| Price To Operating Cash Flow Ratio | -73.943 | -15.835 | -2.245 | -2.907 | -6.146 | |
| Debt To Assets Ratio | 0.069 | 0.089 | 0.082 | 0.076 | 0.051 | |
| Debt To Equity Ratio | 0.104 | 0.135 | 0.114 | 0.098 | 0.065 | |
| Debt To Capital Ratio | 0.094 | 0.119 | 0.102 | 0.089 | 0.061 | |
| Long Term Debt To Capital Ratio | 0.083 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.513 | 1.517 | 1.383 | 1.283 | 1.278 | |
| Working Capital Turnover Ratio | 0.594 | 0.495 | 0.267 | 0.191 | 0.256 | |
| Operating Cash Flow Ratio | -0.195 | -0.865 | -2.232 | -3.295 | -3.797 | |
| Operating Cash Flow Sales Ratio | -0.130 | -0.508 | -1.500 | -2.304 | -3.024 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.264 | 1.065 | 1.059 | 1.108 | 1.042 | |
| Debt Service Coverage Ratio | -45.297 | -16.465 | -56.171 | -84.433 | -14.529 | |
| Interest Coverage Ratio | -57.997 | -59.010 | 0.000 | -96,510.000 | -296.049 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | -17.114 | -45.082 | -87.806 | -136.008 | |
| Operating Cash Flow Coverage Ratio | -0.623 | -1.826 | -3.949 | -5.303 | -6.506 | |
| Capital Expenditure Coverage Ratio | -3.793 | -15.481 | -17.088 | -9.240 | -24.018 | |
| Dividend Paid And Capex Coverage Ratio | -3.793 | -15.481 | -17.088 | -9.240 | -24.018 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -12.006 | -9.759 | -0.912 | -2.218 | -26.027 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 46.9% | ▼-12.7% | ▲4.3% |
| Ebit Margin | -77.3% | ▲9.5% | ▲52.1% |
| Ebitda Margin | -69.0% | ▲5.2% | ▲50.8% |
| Operating Profit Margin | -88.5% | ▲2.1% | ▲105.7% |
| Pretax Profit Margin | -78.8% | ▲9.6% | ▲51.4% |
| Continuous Operations Profit Margin | -79.0% | ▲9.4% | ▲51.4% |
| Net Profit Margin | -79.0% | ▲9.4% | ▲51.4% |
| Bottom Line Profit Margin | -79.0% | ▲9.4% | ▲51.4% |
| Current Ratio | 3.825 | ▼-0.169 | ▼-2.230 |
| Quick Ratio | 2.883 | ▲0.356 | ▼-1.981 |
| Solvency Ratio | -0.686 | ▲0.026 | ▲0.288 |
| Cash Ratio | 2.311 | ▲0.470 | ▼-1.458 |
| Price To Earnings Ratio | -12.258 | ▼-3.082 | ▼-0.011 |
| Price To Earnings Growth Ratio | 1.389 | ▲1.197 | ▲0.989 |
| Forward Price To Earnings Growth Ratio | 1.389 | ▲1.197 | ▲0.989 |
| Price To Earnings Diluted Ratio | -12.258 | ▼-3.082 | ▼-0.011 |
| Price To Earnings Diluted Growth Ratio | 1.389 | ▲1.197 | ▲0.989 |
| Price To Book Ratio | 4.792 | ▲0.880 | ▲2.028 |
| Price To Sales Ratio | 9.621 | ▲1.572 | ▲0.357 |
| Price To Free Cash Flow Ratio | -58.517 | ▼-43.642 | ▼-41.709 |
| Price To Operating Cash Flow Ratio | -73.943 | ▼-58.107 | ▼-53.727 |
| Debt To Assets Ratio | 0.069 | ▼-0.020 | ▼-0.005 |
| Debt To Equity Ratio | 0.104 | ▼-0.031 | ▲0.001 |
| Debt To Capital Ratio | 0.094 | ▼-0.025 | ▲0.001 |
| Long Term Debt To Capital Ratio | 0.083 | ▲0.083 | ▲0.066 |
| Financial Leverage Ratio | 1.513 | ▼-0.004 | ▲0.118 |
| Working Capital Turnover Ratio | 0.595 | ▲0.099 | ▲0.234 |
| Operating Cash Flow Ratio | -0.195 | ▲0.670 | ▲1.882 |
| Operating Cash Flow Sales Ratio | -0.130 | ▲0.378 | ▲1.363 |
| Free Cash Flow Operating Cash Flow Ratio | 1.264 | ▲0.199 | ▲0.156 |
| Debt Service Coverage Ratio | -45.297 | ▼-28.832 | ▼-1.918 |
| Interest Coverage Ratio | -57.997 | ▲1.013 | ▲19326.614 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▲17.114 | ▲57.202 |
| Operating Cash Flow Coverage Ratio | -0.623 | ▲1.204 | ▲3.019 |
| Capital Expenditure Coverage Ratio | -3.793 | ▲11.688 | ▲10.131 |
| Dividend Paid And Capex Coverage Ratio | -3.793 | ▲11.688 | ▲10.131 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -12.006 | ▼-2.247 | ▼-1.821 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $939.1M | $660.5M | $221.8M | $491.6M | $1.16B | |
| Enterprise value | $809.0M | $594.5M | $112.2M | $361.0M | $769.0M | |
| EV / Sales | 8.29x | 7.25x | 1.70x | 4.92x | 12.29x | |
| EV / Op. cash flow | -63.70x | -14.25x | -1.14x | -2.13x | -4.07x | |
| EV / Free cash flow | -50.41x | -13.39x | -1.07x | -1.93x | -3.90x | |
| EV / EBITDA | -12.01x | -9.76x | -0.91x | -2.22x | -26.03x | |
| Net debt / EBITDA | 1.93x | 1.08x | 0.89x | 0.80x | 13.33x | |
| Current ratio | 3.83x | 4.00x | 5.22x | 6.96x | 10.27x | |
| Income quality | 0.17x | 0.57x | 0.74x | 1.00x | 5.84x | |
| Graham net-net | $0 | $0 | $0 | $1 | $2 | |
| Tax burden | 100.1% | 100.0% | 100.1% | 100.0% | 100.4% | |
| Interest burden | 102.0% | 101.8% | 100.0% | 100.0% | 102.1% | |
| Working capital | $184.0M | $144.4M | $187.0M | $305.8M | $462.1M | |
| Invested capital | $220.7M | $187.1M | $238.3M | $358.7M | $500.9M | |
| Return on assets | -26.0% | -28.3% | -43.9% | -40.4% | -5.7% | |
| Operating ROA | -31.3% | -26.6% | -40.3% | -39.0% | -53.6% | |
| Return on tangible assets | -26.7% | -29.3% | -45.5% | -40.4% | -5.7% | |
| Return on equity | -39.3% | -42.9% | -60.8% | -51.9% | -7.2% | |
| Return on invested capital | -36.9% | -35.4% | -55.5% | -52.4% | -36.8% | |
| Return on capital employed | -37.3% | -35.8% | -56.0% | -52.7% | -36.9% | |
| Earnings yield | -8.2% | -11.0% | -60.3% | -34.3% | -2.8% | |
| Free cash flow yield | -1.7% | -6.7% | -47.2% | -38.1% | -16.9% | |
| Capex / Op. cash flow | -26.4% | -6.5% | -5.9% | -10.8% | -4.2% | |
| Capex / Depreciation | 41.4% | 26.0% | 54.7% | 308.4% | 376.9% | |
| Capex / Sales | 3.4% | 3.3% | 8.8% | 24.9% | 12.6% | |
| SG&A / Sales | 87.2% | 104.1% | 162.1% | 196.8% | 216.3% | |
| R&D / Sales | 37.1% | 46.1% | 84.4% | 120.0% | 119.0% | |
| Stock comp / Sales | 24.0% | 25.6% | 41.7% | 58.0% | 76.4% | |
| Intangibles / Total assets | 2.5% | 3.5% | 3.4% | 0.0% | 0.0% | |
| Days sales outstanding | 100d | 92d | 74d | 73d | 70d | |
| Days payables outstanding | 38d | 47d | 38d | 78d | 46d | |
| Operating cycle | 532d | 870d | 618d | 718d | 360d | |
| Cash conversion cycle | 494d | 823d | 580d | 641d | 314d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+42.2%EV / Sales ▲+14.4%EV / EBITDA ▼-23.0%EV / Op. cash flow ▼-49.445Earnings yield ▲+0.028
Profitability
Return on equity ▲+0.036Return on assets ▲+0.023Return on invested capital ▼-0.015Return on capital employed ▼-0.015Operating ROA ▼-0.047Income quality ▼-0.411Tax burden ▲+0.002
Efficiency
Days sales outstanding ▲+7.515Days payables outstanding ▼-8.399Operating cycle ▼-338.219Cash conversion cycle ▼-329.819Capex / Sales ▲+0.001R&D / Sales ▼-0.089
Balance-sheet strength
Current ratio ▼-0.169Net debt / EBITDA ▲+0.848Working capital ▲+39588000.000Invested capital ▲+33676000.000Intangibles / Total assets ▼-0.009
Change over 5 years
Valuation
Market cap ▼-19.2%EV / Sales ▼-32.6%EV / EBITDA ▲+53.9%EV / Op. cash flow ▼-59.634Earnings yield ▼-0.054
Profitability
Return on equity ▼-0.321Return on assets ▼-0.203Return on invested capital ▼-0.001Return on capital employed ▼-0.004Operating ROA ▲+0.223Income quality ▼-5.673Tax burden ▼-0.002
Efficiency
Days sales outstanding ▲+30.372Days payables outstanding ▼-8.210Operating cycle ▲+171.635Cash conversion cycle ▲+179.845Capex / Sales ▼-0.092R&D / Sales ▼-0.819
Balance-sheet strength
Current ratio ▼-6.448Net debt / EBITDA ▼-11.396Working capital ▼-278089000.000Invested capital ▼-280120000.000Intangibles / Total assets n/a
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-09-23 Butterfly Stock Retreats: What''s Going On Today? Butterfly Network Inc. (NYSE:BFLY) shares are falling Wednesday, pulling back after the stock soared Tuesday on a bullish analyst initiation.
- 2026-09-23 Butterfly Network (BFLY) Surges 22.0%: Is This an Indication of Further Gains? Butterfly Network (BFLY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- 2026-09-15 Executive Waves Goodbye to Nearly 14,000 Shares, Valued at More Than $100,000 The CAO sold 13,804 shares at $7.30 per share for a total transaction value of ~$101,000 on September 4, 2026. The transaction size represents 3% of the direct equity holdings held before the filing.
- 2026-09-15 Butterfly Network, Inc. (BFLY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Butterfly Network, Inc. (BFLY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- 2026-09-14 Zacks Industry Outlook Medical Systems, American Well and Butterfly Network Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.
- 2026-09-11 3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.
- 2026-09-08 Butterfly Network to Participate in Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026 NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound, cloud software and AI, today announced that it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on September 15, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer; and Megan Carlson, SVP, Accounting & Finance – Chief Accounting.
- 2026-09-01 Merge Labs and Butterfly Network Partner to Advance Ultrasound-Based Brain-Computer Interfaces BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, and Merge Labs today announced a multi-year licensing agreement through Butterfly Embedded™. The agreement gives Merge access to Butterfly''s Poseidon Family of Ultrasound-on-Chip™ technology for the development of ultrasound-based brain-computer interfaces (BCI). Merge Labs was founded with the long-term mi.
- 2026-08-21 Butterfly Network Director Phanstiel Buys $1.0 Million in Stock. Is This a Sign Investors Should Also Buy? Louise S. Phanstiel acquired ~115,000 shares at $8.68 per share, representing a total transaction value of $1.0 million. The purchase increased the director''s total equity holdings by 20% and indirect holdings by 62%.
- 2026-08-13 Butterfly Network CEO Joseph Devivo Sells 68,346 Shares 68,346 shares were sold for ~$684,143 on August 10, 2026. The transaction represents a 0.89% reduction in direct equity holdings.